Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rollover study of Fosbretabulin in PNET/GI-NET
NCT02279602Phase 2Completed
- Sponsor
- Oncotelic Therapeutics, Inc.
- Start
- Dec 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosbretabulin in neuroendocrine tumors (NETs), sponsored by Oncotelic Therapeutics, Inc.. Started Dec 2014; status: completed.
02
Drugs
fosbretabulin
03
Conditions
neuroendocrine tumors (NETs)
Beyond the preview
Go deeper on NCT02279602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279602.